US Stock MarketDetailed Quotes
UBX Unity Biotechnology
- 1.4500
- -0.0700-4.61%
Close Sep 6 16:00 ET
- 1.5200
- +0.0700+4.83%
Post 20:02 ET
24.43MMarket Cap-755P/E (TTM)
1.5300High1.4400Low37.37KVolume1.5300Open1.5200Pre Close54.98KTurnover0.26%Turnover RatioLossP/E (Static)16.85MShares2.600052wk High1.24P/B21.25MFloat Cap1.220052wk Low--Dividend TTM14.66MShs Float245.6000Historical High--Div YieldTTM5.92%Amplitude1.2200Historical Low1.4710Avg Price1Lot Size
Unity Biotechnology Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 58.64%-4.58M | 54.20%-5.18M | 29.24%-37.09M | 35.54%-7.58M | 34.47%-7.11M | 25.29%-11.08M | 24.42%-11.32M | -16.32%-52.41M | -133.66%-11.75M | 6.06%-10.86M |
| Net income from continuing operations | 65.84%-5.28M | -9.68%-5.79M | 10.36%-39.86M | -216.21%-1.5M | -28.61%-17.63M | -17.65%-15.46M | 72.09%-5.28M | 26.77%-44.47M | 112.05%1.29M | 16.68%-13.71M |
| Operating gains losses | -136.00%-1.25M | 74.65%-1.39M | 70.27%-5.17M | 66.59%-5.66M | 2,726.04%2.52M | 2,392.05%3.46M | -2,659.30%-5.49M | -14,036.59%-17.39M | ---16.94M | ---96K |
| Depreciation and amortization | -29.62%221K | -31.00%227K | -45.78%1.18M | -43.52%231K | -42.43%308K | -48.44%314K | -47.53%329K | -24.31%2.18M | -39.05%409K | -24.44%535K |
| Other non cash items | -1,055.56%-312K | -781.82%-300K | 55.13%-367K | -410.71%-261K | 64.55%-123K | 89.24%-27K | 114.47%44K | -186.74%-818K | 139.07%84K | -118.28%-347K |
| Change In working capital | 203.84%1.27M | 135.29%939K | -329.65%-4.39M | -151.55%-815K | -50.48%309K | 71.23%-1.22M | -358.85%-2.66M | -61.97%-1.02M | -28.62%1.58M | 158.70%624K |
| -Change in prepaid assets | 136.72%325K | 197.44%1.22M | -1,305.80%-1.66M | -87.01%194K | 158.85%276K | 11.14%-885K | -1,235.45%-1.25M | -89.29%138K | 12.17%1.49M | -203.08%-469K |
| -Change in payables and accrued expense | 373.28%992K | 86.06%-200K | -125.60%-2.65M | -1,479.69%-883K | -97.47%28K | 88.92%-363K | -254.63%-1.44M | 61.20%-1.18M | 120.65%64K | 178.34%1.11M |
| -Change in other current assets | -291.67%-46K | -439.13%-78K | -289.74%-74K | -625.00%-126K | 135.71%5K | 60.00%24K | 64.29%23K | 142.86%39K | 71.43%24K | 86.67%-14K |
| -Change in other current liabilities | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -102.33%-23K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 58.64%-4.58M | 54.20%-5.18M | 29.24%-37.09M | 35.54%-7.58M | 34.47%-7.11M | 25.29%-11.08M | 24.42%-11.32M | -16.32%-52.41M | -133.66%-11.75M | 6.06%-10.86M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -52.61%4.67M | -133.79%-7.19M | 346.47%60.5M | 8,013.09%15.11M | 139.33%14.25M | -44.31%9.85M | 465.79%21.28M | -162.43%-24.55M | -102.10%-191K | -311.23%-36.23M |
| Net PPE purchase and sale | --0 | --19K | -63.12%104K | 65.22%114K | -116.39%-10K | --0 | --0 | 244.62%282K | 1,085.71%69K | 162.24%61K |
| Net investment purchase and sale | -52.61%4.67M | -133.88%-7.21M | 343.25%60.39M | 5,869.23%15M | 139.29%14.26M | -43.82%9.85M | 465.79%21.28M | -162.84%-24.83M | -102.86%-260K | -310.38%-36.29M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -52.61%4.67M | -133.79%-7.19M | 346.47%60.5M | 8,013.09%15.11M | 139.33%14.25M | -44.31%9.85M | 465.79%21.28M | -162.43%-24.55M | -102.10%-191K | -311.23%-36.23M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 102.59%68K | 0 | -129.05%-16.34M | 182.73%4.39M | -136.59%-18.38M | -2,002.17%-2.63M | -93.67%274K | 169.80%56.24M | -77.38%1.55M | 1,631.72%50.22M |
| Net issuance payments of debt | ---- | ---- | ---20M | --0 | ---16.77M | ---- | ---- | --0 | --0 | --0 |
| Net common stock issuance | --0 | --0 | -91.20%5.11M | 24.59%4.36M | -100.10%-48K | 3,884.62%518K | -93.67%274K | 212.65%58.07M | -48.34%3.5M | 1,631.72%50.22M |
| Proceeds from stock option exercised by employees | ---- | ---- | -18.31%116K | 47.06%25K | --0 | ---- | ---- | -93.34%142K | -88.74%17K | --0 |
| Net other financing activities | ---- | ---- | 20.54%-1.56M | --0 | ---- | ---- | ---- | -1,036.67%-1.97M | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 102.59%68K | --0 | -129.05%-16.34M | 182.73%4.39M | -136.59%-18.38M | -2,002.17%-2.63M | -93.67%274K | 169.80%56.24M | -77.38%1.55M | 1,631.72%50.22M |
| Net cash flow | ||||||||||
| Beginning cash position | -65.12%8.33M | 51.84%20.7M | -60.32%13.63M | -63.48%8.77M | -4.18%20.01M | 33.40%23.87M | -60.32%13.63M | 78.42%34.35M | 2.48%24.02M | 39.78%20.89M |
| Current changes in cash | 104.00%154K | -220.88%-12.37M | 134.11%7.07M | 214.79%11.93M | -458.71%-11.24M | -228.64%-3.85M | 162.19%10.24M | -237.23%-20.72M | -195.23%-10.39M | -63.11%3.13M |
| End cash Position | -57.63%8.48M | -65.12%8.33M | 51.84%20.7M | 51.84%20.7M | -63.48%8.77M | -4.18%20.01M | 33.40%23.87M | -60.32%13.63M | -60.32%13.63M | 2.48%24.02M |
| Free cash flow | 58.64%-4.58M | 54.20%-5.18M | 29.35%-37.1M | 35.74%-7.58M | 34.66%-7.13M | 25.35%-11.08M | 24.42%-11.32M | -16.03%-52.51M | -134.07%-11.79M | 6.44%-10.9M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg